In vitro effects of stem-cell factor or interleukin-3 on myelosuppression associated with AIDS

Publisher Website
Google Scholar
Abstract
To determine whether the early-acting hematopoietic growth factors stem-cell factor (SCF) or interleukin-3 (IL-3), are able to overcome the bone-marrow suppressive effects of cytokines or drugs involved in the hematologic abnormalities that accompany HIV-1 infection. In vitro colony formation assays of normal human bone-marrow cells exposed to the myelosuppressive drugs, zidovudine, interferon-α (IFN-α) and ganciclovir, or the myelosuppressive cytokines, tumor necrosis factor-α (TNF-α) or transforming growth factor-β (TGF-β), implicated in HIV dysmyelopoiesis. SCF (10ng/ml) enhanced the numbers of erythroid (BFU-E) colonies in the presence of zidovudine or ganciclovir (P Conclusions These data suggest that SCF or IL-3 may have a therapeutic application in overcoming hematopoietic abnormalities associated with drugs commonly used in the care of AIDS patients. However, they may have less capacity to overcome the bone-marrow inhibitory effects of the endogenous cytokines TNF-α and TGF-β.

This publication has 0 references indexed in Scilit: